Approaches in broadening the neutralizing antibody response of the influenza vaccine
- 4 October 2021
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 20 (12) , 1539-1547
Abstract
Influenza vaccine is the mainstay for influenza prevention and elicits immune response and antigen-specific neutralizing antibodies against influenza virus. However, antigenic drift and shift can c...Keywords
This publication has 92 references indexed in Scilit:
- DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+ T-Cell Responses after rAd5 Boost in a Randomized Clinical TrialPLOS ONE, 2013
- Assessment of Antigen-Specific and Cross-Reactive Antibody Responses to an MF59-Adjuvanted A/H5N1 Prepandemic Influenza Vaccine in Adult and Elderly SubjectsClinical and Vaccine Immunology, 2012
- Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvantVaccine, 2012
- Complement-Dependent Lysis of Influenza A Virus-Infected Cells by Broadly Cross-Reactive Human Monoclonal AntibodiesJournal of Virology, 2011
- Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunityVaccine, 2011
- The development of vaccine viruses against pandemic A(H1N1) influenzaVaccine, 2011
- H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell ResponsesJournal of Clinical Immunology, 2010
- Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineagesVaccine, 2009
- FluBlok, a next generation influenza vaccine manufactured in insect cellsBiologicals, 2009
- Vaccines with the MF59 Adjuvant Do Not Stimulate Antibody Responses against SqualeneClinical and Vaccine Immunology, 2006